These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2276976

  • 1. Deoxyspergualin therapy in autoimmune MRL/1pr mice suffering advanced lupus-like disease.
    Nemoto K, Mae T, Sugawara Y, Hayashi M, Abe F, Takeuchi T.
    J Antibiot (Tokyo); 1990 Dec; 43(12):1590-6. PubMed ID: 2276976
    [Abstract] [Full Text] [Related]

  • 2. 15-Deoxyspergualin (15-DOS) has a curative effect on the development of SLE-like autoimmune disease in MRL/1 mice.
    Schorlemmer HU, Bartlett RR, Seiler FR.
    Agents Actions; 1991 Sep; 34(1-2):151-5. PubMed ID: 1793021
    [Abstract] [Full Text] [Related]

  • 3. Biological activities of deoxyspergualin in autoimmune disease mice.
    Nemoto K, Hayashi M, Sugawara Y, Ito J, Abe F, Takita T, Nakamura T, Takeuchi T.
    J Antibiot (Tokyo); 1988 Sep; 41(9):1253-9. PubMed ID: 3263348
    [Abstract] [Full Text] [Related]

  • 4. Effect of spergualin in autoimmune disease mice.
    Nemoto K, Hayashi M, Ito J, Abe F, Takita T, Nakamura T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1987 Oct; 40(10):1448-51. PubMed ID: 3680010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunosuppressive activities of deoxyspergualin. I. Effect of the long-term administration of the drug on the development of murine lupus.
    Makino M, Fujiwara M, Aoyagi T, Umezawa H.
    Immunopharmacology; 1987 Oct; 14(2):107-13. PubMed ID: 3429222
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the ameliorative effects of immunosuppressants on crescentic glomerulonephritis in SCG/Kj mice.
    Saiga K, Yoshida M, Nakamura I, Toyoda E, Tokunaka K, Morohashi H, Abe F, Nemoto K, Nose M.
    Int Immunopharmacol; 2008 Sep; 8(9):1183-9. PubMed ID: 18602063
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
    Liu CP, Tsai WJ, Shen CC, Lin YL, Liao JF, Chen CF, Kuo YC.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):270-9. PubMed ID: 16413531
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses.
    Ito S, Ueno M, Arakawa M, Saito T, Aoyagi T, Fujiwara M.
    Clin Exp Immunol; 1990 Sep 15; 81(3):446-53. PubMed ID: 2397613
    [Abstract] [Full Text] [Related]

  • 12. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 15; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 13. Effects of deoxyspergualin on dipeptidyl peptidase-II and -IV in the spleen of BXSB mice and MRL/lpr mice during the development of the lupus erythematosus-like syndrome.
    Hagihara M, Sekiguchi K, Fujiwara M, Aoyagi T, Takeuchi T, Nagatsu T.
    Biochem Pharmacol; 1992 Mar 17; 43(6):1380-3. PubMed ID: 1348619
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA, Lee B, Burek CL, Saboori AM, Prendergast RA.
    Invest Ophthalmol Vis Sci; 1996 Feb 17; 37(2):377-83. PubMed ID: 8603842
    [Abstract] [Full Text] [Related]

  • 16. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice.
    Entani C, Izumino K, Iida H, Fujita M, Asaka M, Takata M, Sasayama S.
    Nephron; 1993 Feb 17; 64(3):471-5. PubMed ID: 7688103
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
    Hoi AY, Hickey MJ, Hall P, Yamana J, O'Sullivan KM, Santos LL, James WG, Kitching AR, Morand EF.
    J Immunol; 2006 Oct 15; 177(8):5687-96. PubMed ID: 17015758
    [Abstract] [Full Text] [Related]

  • 20. The effect of danazol in the MRL/lpr mouse model of autoimmune disease.
    Connolly KM, Stecher VJ, Snyder BW, Bohnet E, Potts GO.
    Agents Actions; 1988 Aug 15; 25(1-2):164-70. PubMed ID: 3189043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.